Assessing psychosis risk using quantitative markers of transcribed speech

Duration: 22 mins 58 secs
Share this media item:
Embed this media item:


About this item
Image inherited from collection
Description: Talk by Dr Sarah Morgan, Accelerate Science Research Fellow at the Dept. of Computer Science & Technology, Senior Research Associate at the Cambridge Brain Mapping Unit, and Fellow at The Alan Turing Institute
 
Created: 2021-06-30 22:12
Collection: Cambridge Language Sciences
Language sciences research symposium for early-career researchers, 2021
Publisher: University of Cambridge
Copyright: Dr Sarah Morgan
Language: eng (English)
Distribution: World     (downloadable)
Keywords: mental health diagnostics; Natural Language Processing; schizophrenia; psychosis;
Explicit content: No
Aspect Ratio: 4:3
Screencast: No
Bumper: UCS Default
Trailer: UCS Default
 
Abstract: There is a pressing clinical demand for tools to predict individual patients' disease trajectories for schizophrenia and other conditions involving psychosis, however to date such tools have proved elusive.

Behaviourally and cognitively, psychosis expresses itself by subtle alterations in language. Recent work has suggested that Natural Language Processing markers of transcribed speech might be powerful predictors of later psychosis (Mota et al 2017, Corcoran et al 2018), for example, Corcoran et al 2018 used quantitative markers of semantic coherence collected at baseline from individuals at clinical high risk for psychosis, to predict transition to psychosis with 79% accuracy.

However, it remains unclear which NLP measures are most likely to be predictive, how different NLP measures relate to each other and how best to collect speech data from patients. In this talk, I will discuss our research tackling these questions, as well as the wider challenges of translating this type of approach to the clinic. Ultimately, computational markers of speech have the potential to transform healthcare of mental health conditions such as schizophrenia, since they are relatively easy to collect and could be measured longitudinally to quickly identify changes in patients' disease trajectories.
Available Formats
Format Quality Bitrate Size
MPEG-4 Video 640x360    1.44 Mbits/sec 249.33 MB View Download
WebM 640x360    826.1 kbits/sec 139.06 MB View Download
iPod Video 480x360    515.55 kbits/sec 86.72 MB View Download
MP3 44100 Hz 249.76 kbits/sec 42.07 MB Listen Download
Auto * (Allows browser to choose a format it supports)